Carmignac Gestion Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$264M |
| 2 |
Johnson & Johnson
JNJ
|
+$262M |
| 3 |
CELG
Celgene Corp
CELG
|
+$134M |
| 4 |
Las Vegas Sands
LVS
|
+$61.5M |
| 5 |
Comcast
CMCSA
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$734M |
| 2 |
Core Laboratories
CLB
|
+$604M |
| 3 |
Baidu
BIDU
|
+$320M |
| 4 |
HOT
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
|
+$167M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 30.51% |
| 2 | Communication Services | 19.55% |
| 3 | Healthcare | 16.47% |
| 4 | Energy | 11.08% |
| 5 | Consumer Discretionary | 8.86% |
Similar funds
Carmignac Gestion's Q2 2014 Portfolio in Review
As of Q2 2014, Carmignac Gestion held 31 positions worth $12.8B, down 6.3% from $13.7B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Carmignac Gestion withdrew a net $1.53B in Q2 2014, closing 5 positions and reducing 9 holdings. Its most notable exit was LyondellBasell Industries, an estimated $734M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Carmignac Gestion opened a new position in Intercept Pharmaceuticals, Inc. worth $237M.
- Carmignac Gestion's largest Q2 2014 buy was Intercept Pharmaceuticals, Inc.: 1,000,576 shares worth $237M.
- Carmignac Gestion added most to Celgene Corp in Q2 2014, an estimated $134M increase.
- Carmignac Gestion's biggest Q2 2014 reduction was Baidu, cutting an estimated $320M.
- Carmignac Gestion fully exited LyondellBasell Industries in Q2 2014, selling an estimated $734M.
- Carmignac Gestion's ten largest holdings make up 56% of its $12.8B portfolio in Q2 2014.
- Carmignac Gestion opened 2 new positions and closed 5 in Q2 2014.
- Carmignac Gestion's portfolio value fell 6.3% quarter-over-quarter to $12.8B.
Based on Carmignac Gestion's 13F filing for Q2 2014, filed 6 Aug 2014.